<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Caridha D</submitter><funding>Military Infectious Disease Research Program</funding><funding>Military Infectious Disease Research Program (MIDRP)</funding><pagination>38</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6376706</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>18(1)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Rodent malaria models are extensively used to predict treatment outcomes in human infections. There is a constant need to improve and refine these models by innovating ways to apply new scientific findings and cutting edge technologies. In addition, and in accordance with the three R's of animal use in research, in vivo studies should be constantly refined to avoid unnecessary pain and distress to the experimental animals by using preemptive euthanasia as soon as the main scientific study objective has been accomplished.&lt;h4>Methods&lt;/h4>The new methodology described in this manuscript uses the whole-body bioluminescence signal emitted by transgenic, luciferase-expressing Plasmodium berghei parasites to assess the parasite load predicted parasitaemia (PLPP) in drug and con</pubmed_abstract><journal>Malaria journal</journal><pubmed_title>Updating the modified Thompson test by using whole-body bioluminescence imaging to replace traditional efficacy testing in experimental models of murine malaria.</pubmed_title><pmcid>PMC6376706</pmcid><funding_grant_id>proposal #Q0433_15_WR_CS_OC.</funding_grant_id><funding_grant_id>Area Q - Anti-parasitic drugs</funding_grant_id><pubmed_authors>Milner E</pubmed_authors><pubmed_authors>Lee P</pubmed_authors><pubmed_authors>Roncal N</pubmed_authors><pubmed_authors>Hosford E</pubmed_authors><pubmed_authors>Leed S</pubmed_authors><pubmed_authors>Lee J</pubmed_authors><pubmed_authors>Xie L</pubmed_authors><pubmed_authors>Vesely B</pubmed_authors><pubmed_authors>Li Q</pubmed_authors><pubmed_authors>Ngundam F</pubmed_authors><pubmed_authors>Caridha D</pubmed_authors><pubmed_authors>Schenk A</pubmed_authors><pubmed_authors>Black C</pubmed_authors><pubmed_authors>Reichard G</pubmed_authors><pubmed_authors>Kreishman-Deitrick M</pubmed_authors><pubmed_authors>Nugent D</pubmed_authors><pubmed_authors>Hickman M</pubmed_authors><pubmed_authors>Butler K</pubmed_authors><pubmed_authors>Sciotti RJ</pubmed_authors></additional><is_claimable>false</is_claimable><name>Updating the modified Thompson test by using whole-body bioluminescence imaging to replace traditional efficacy testing in experimental models of murine malaria.</name><description>&lt;h4>Background&lt;/h4>Rodent malaria models are extensively used to predict treatment outcomes in human infections. There is a constant need to improve and refine these models by innovating ways to apply new scientific findings and cutting edge technologies. In addition, and in accordance with the three R's of animal use in research, in vivo studies should be constantly refined to avoid unnecessary pain and distress to the experimental animals by using preemptive euthanasia as soon as the main scientific study objective has been accomplished.&lt;h4>Methods&lt;/h4>The new methodology described in this manuscript uses the whole-body bioluminescence signal emitted by transgenic, luciferase-expressing Plasmodium berghei parasites to assess the parasite load predicted parasitaemia (PLPP) in drug and con</description><dates><release>2019-01-01T00:00:00Z</release><publication>2019 Feb</publication><modification>2025-04-25T23:22:58.965Z</modification><creation>2019-08-04T07:56:56Z</creation></dates><accession>S-EPMC6376706</accession><cross_references><pubmed>30767768</pubmed><doi>10.1186/s12936-019-2661-x</doi></cross_references></HashMap>